AAAhmad Asadi Ardebili

Ahmad Asadi Ardebili

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmad Asadi Ardebili has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The role of Cannabinoid receptors in visceral pain sensation of rat: an interventional study

    by Seyed Mohammad Nabavi, Mohammadreza Rahimnejad, Ahmad Asadi Ardebili, Ramin Hajikhani

    Visceral pain, originating from internal organs, represents a challenging aspect of pain management due to its intricate mechanisms and often debilitating nature. Understanding the underlying pathways involved in visceral pain perception is crucial for developing effective therapeutic strategies. The current study aimed to delve into recent advancements in the understanding of cannabinergic modulation of visceral pain perception, focusing on findings from interventional studies utilizing animal models, particularly rats. A total of 30 male rats aged 3 months, with an average weight of 220 g were randomly divided into 3 groups. The groups contained the control group which received intraperitoneal injection of normal saline, the second group received an intraperitoneal injection of anandamide (2 mg/kg), and the third group received an intraperitoneal injection of tramadol (20 mg/kg). The pain in all groups assessed by acetic acid test. The data obtained from the intraperitoneal injection of anandamide to the rats of the experimental group showed a significant decrease in the amount of perceived visceral pain compared to control group. In addition, the results showed that tramadol injection significantly decreased visceral pain in experimental group 2 compared to the control group. In conclusion, the current study provides an evidence for the involvement of cannabinoid receptors in the modulation of visceral pain sensation in rats.


  • Open Access

    The Effect of Systemic Administration of Monoterpenes on Visceral Pain in an Animal Model

    by Ahmad Asadi Ardebili

    Introduction: Pain is one of the primary and fundamental issues associated with various diseases that every individual will encounter throughout their lifetime. Non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are commonly used for pain control, but they have significant side effects. The current study aimed to evaluate the effect of systemic administration of monoterpenes on visceral pain in an animal model. Materials and methods: In this experimental study, 30 male albino rats weighing approximately 21 to 25 grams were used. The rats were randomly divided into three groups of 10. The control group did not receive any drug, while the first treatment group received d-limonene orally at a dose of 10 milligrams per kilogram, known as a monoterpene compound. The second treatment group received tramadol orally at a dose of 20 milligrams per kilogram. To assess the effects of monoterpenes on colonic pain, intraperitoneal injection of 6% acetic acid (4 mg/kg) was used, and the number of reflex contractions, which could be easily distinguishable and lasted for several seconds, was observed and counted for 90 minutes. Data were collected and averaged every 5 minutes and then subjected to initial statistical analysis. Results: A significant difference in terms of visceral pain was observed between these two groups. The rats in the first treatment group that received limonene perceived significantly less visceral pain than those in the control group. The findings indicated a significant difference between treatment groups 1 and 2, meaning that tramadol creates a greater analgesic effect. Conclusion: This finding suggests that monoterpenes cannot produce the same level of analgesic effects on visceral pain as opioids.


  • Open Access

    Successful Treatment of Urolith in a Neutered Persian Cat: A Case Report

    by Ahmad Asadi Ardebili, Seyed Amin Razavi

    Introduction: Uroliths or calculi are the formations of stones in the bladder. The formation of stones is influenced by specific metabolic conditions such as nutritional factors (e.g., protein-rich diet), hydration (lack of water), pH modification, low urine volume, hypercalcemia, or hypophosphatemia. In pet medicine, urolithiasis is common, particularly in cats. Case report: In October 2022, a 2-year-old neutered male Persian cat with a weight of 4 kg was referred to Ardebili Veterinary Pet Clinic (Mashhad, Iran) due to urinating outside the litter box, painful urination, and blood in the urine. A physical examination, ultrasonography, and blood analysis were performed. The physical examination included an assessment of the cat’s body temperature, heart rate, respiratory rate, mental state, mucous membrane color, capillary refill time, cardiopulmonary auscultation, and abdominal palpation. The cat appeared to be in good general health. No abnormalities were detected during the palpation of the bladder. Ultrasonography was performed using a real-time scanner with a 7.5-10 MHz broadband curvilinear probe, and the kidney parenchyma was examined. During the examination, a urolith with a size of 1 mm was observed. According to history and ultrasonography, and physical examination, the diagnosis was urolithiasis. To treat intermittent bladder pain, a spasmolytic drug (Prazosin) was administered at a dose of 0.5 mg/kg for 7 days. By the second day, the symptoms of pain had subsided. Additionally, ciprofloxacin at 20 mg/kg was used to combat infections. Fluoxetine at a 1 mg/kg dose was also administered to control inappropriate urination outside the litter box. After 3 days, the owner reported that the pet’s health improved, and most clinical signs disappeared. Conclusion: Administering appropriate medication (spasmolytic drug, antibiotic, and antidepressant in case of depressed animal and behavioral problems) can alleviate the calculi crystals in a cat’s urinary bladder and prevent future recurrences. In this instance, fluoxetine was discovered to be a successful option for managing pain and solving behavioral problems.